Call Options

8 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q2 2022

Aug 15, 2022

BUY
$53.22 - $123.09 $356,574 - $824,703
6,700 Added 67.0%
16,700 $988,000
Q4 2020

Feb 16, 2021

SELL
$86.4 - $121.75 $864,000 - $1.22 Million
-10,000 Reduced 50.0%
10,000 $957,000
Q3 2020

Nov 16, 2020

SELL
$95.43 - $116.09 $1.91 Million - $2.32 Million
-20,000 Reduced 50.0%
20,000 $2.27 Million
Q4 2019

Feb 14, 2020

SELL
$53.13 - $71.19 $47,817 - $64,071
-900 Reduced 2.2%
40,000 $2.38 Million
Q3 2019

Nov 14, 2019

SELL
$57.11 - $73.3 $845,228 - $1.08 Million
-14,800 Reduced 26.57%
40,900 $2.41 Million
Q2 2019

Aug 14, 2019

SELL
$54.41 - $71.7 $1.21 Million - $1.6 Million
-22,300 Reduced 28.59%
55,700 $3.59 Million
Q1 2019

May 15, 2019

BUY
$32.25 - $73.56 $1.9 Million - $4.33 Million
58,900 Added 308.38%
78,000 $4.95 Million
Q4 2018

Feb 14, 2019

BUY
$28.45 - $40.65 $543,395 - $776,415
19,100 New
19,100 $725,000

Others Institutions Holding TNDM

About TANDEM DIABETES CARE INC


  • Ticker TNDM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 64,221,200
  • Market Cap $1.98B
  • Description
  • Tandem Diabetes Care, Inc., a medical device company, designs, develops, and commercializes various products for people with insulin-dependent diabetes in the United States and internationally. The company's flagship product is the t:slim X2 insulin delivery system, a pump platform that comprises t:slim X2 pump, its 300-unit disposable insulin c...
More about TNDM
Track This Portfolio

Track D. E. Shaw & Co., Inc. Portfolio

Follow D. E. Shaw & Co., Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

News

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.